World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-DDD-17010794
Date of registration: 2017-03-05
Prospective Registration: No
Primary sponsor: Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital
Public title: The study on early diagnosis of Parkinson 's disease by transcranial ultrasonography
Scientific title: the study on early diagnosis of Parkinson 's disease by transcranial ultrasonography
Date of first enrolment: 2014-11-08
Target sample size: Target condition:135;Difficult condition:0
Recruitment status: Completed
URL:  http://www.chictr.org.cn/showproj.aspx?proj=18272
Study type:  Diagnostic test
Study design:  Diagnostic test for accuracy  
Phase:  Diagnostic New Technique Clincal Study
Countries of recruitment
China
Contacts
Name: Qinyong Ye   
Address:  Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian, China 350001
Telephone: +86 0591-83357896?8455
Email: unionqyye@163.com
Affiliation:  Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital
Name: Qinyong Ye   
Address:  Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian, China 350001
Telephone: +86 0591-83357896?8455
Email: unionqyye@163.com
Affiliation:  Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital
Key inclusion & exclusion criteria
Inclusion criteria: 67 Parkinson's disease patients in our research came from Department of Neurology, Fujian Medical University Union Hospital. They were diagnosed by Queen Square Brain Bank UK PDS Brain Bank Criteria for the diagnosis of PD as the case group. Their ages were ranged from 36 to 84 years old, the average age was (67.18 ± 9.912) years old. All PD patients underwent UPDRS-III, and Hoehn-Yahr Rating Scale (H-Y). The UPDRS results can be divided into mild (below 10 points), moderate (11-20), severe (21-30).
Exclusion criteria: In this research, 68 participants, without family history of PD and ruling out Parkinson’syndrome, Vascular Parkinsonism and the other extrapyramidal disease, were recruited as the control group. The both groups matched in age and gender.

Age minimum: 36
Age maximum: 84
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson's Disease
Intervention(s)
Gold Standard:Diagnosis of Parkinson disease needs to meet 3 or more: unilateral onset;resting tremor;progressive course; long term asymmetry, the most obvious symptoms is the onset side; a good response to levodopa (70% ~ 100%); levodopa induced chorea; a reaction of levodopa lasts 5 years or more; clinical course last;Index test:Laboratory apparatus
As shown in Figure 1, The ultrasound equipment, Philips IE33-BOMJH1 color Doppler ultrasonography, Model IE-ELite, with 2-4MHz phased array probe (S5-1 probe) was used for TCS to examine SN in our study.
Transcranial ultrasound study
Ultrasonography through temporal window, alon;
Primary Outcome(s)
the area of the echogenic signals in the substantia nigra;the intensity of the echogenic signals in the substantia nigra;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
the National Natural Science Foundation of China (General Program)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history